Urgent Surgery-related Bleeding Risk

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2023-03-08
Clinical Trial Update: Study of Octaplex, a Four-factor Prothrombin Complex Concentrate (4F-PCC) and Beriplex® P/N (Kcentra) for the Reversal of Vitamin K Antagonist (VKA) Induced Anticoagulation in Patients Needing Urgent Surgery With Significant Bleeding Risk. [Phase 3]
Phase 3 trial assessing 4F-PCC (Octaplex) versus Beriplex/Kcentra for reversal of vitamin K antagonist anticoagulation in patients needing u…